NADPH oxidase 4 (NOX4) as a biomarker and therapeutic target in neurodegenerative diseases
Neural Regeneration Research · 2024-09 · 19 (9) · 1961-1966
DOI: 10.4103/1673-5374.390973 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neural Regeneration Research, online erschienen am 15.12.2023. Verfasst von Napissara Boonpraman und 1 weiteren Autor:innen. Beteiligte Einrichtung: BK21 four Program, Department of Medical Sciences, Soonchunhyang University, Asan, South Korea. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Diseases like Alzheimer's and Parkinson's diseases are defined by inflammation and the damage neurons undergo due to oxidative stress. A primary reactive oxygen species contributor in the central nervous system, NADPH oxidase 4, is viewed as a potential therapeutic touchstone and indicative marker for these ailments. This in-depth review brings to light distinct features of NADPH oxidase 4, responsible for generating superoxide and hydrogen peroxide, emphasizing its pivotal role in activating glial cells, inciting inflammation, and disturbing neuronal functions. Significantly, malfunctioning astrocytes, forming the majority in the central nervous system, play a part in advancing neurodegenerative diseases, due to their reactive oxygen species and inflammatory factor secretion. Our study reveals that aiming at NADPH oxidase 4 within astrocytes could be a viable treatment pathway to reduce oxidative damage and halt neurodegenerative processes. Adjusting NADPH oxidase 4 activity might influence the neuroinflammatory cytokine levels, including myeloperoxidase and osteopontin, offering better prospects for conditions like Alzheimer's disease and Parkinson's disease. This review sheds light on the role of NADPH oxidase 4 in neural degeneration, emphasizing its drug target potential, and paving the path for novel treatment approaches to combat these severe conditions.
Autor:innen und Institutionen
- BK21 four Program, Department of Medical Sciences, Soonchunhyang University, Asan, South Korea.
- Department of Biomedical Laboratory Science, Soonchunhyang University, Asan, South Korea.
- iConnectome, Co., Ltd., Cheonan, South Korea.
ORCID-Profile: Sun Shin Yi
Zitieren
APA
Boonpraman, N., & Yi, S. S. (2024). NADPH oxidase 4 (NOX4) as a biomarker and therapeutic target in neurodegenerative diseases. Neural Regeneration Research, 19(9), 1961-1966. https://doi.org/10.4103/1673-5374.390973
Vancouver
Boonpraman N, Yi SS. NADPH oxidase 4 (NOX4) as a biomarker and therapeutic target in neurodegenerative diseases. Neural Regeneration Research. 2024;19(9):1961-1966. doi:10.4103/1673-5374.390973
BibTeX
@article{Boonpraman2024,
author = {Boonpraman, Napissara and Yi, Sun Shin},
title = {NADPH oxidase 4 (NOX4) as a biomarker and therapeutic target in neurodegenerative diseases},
journal = {Neural Regeneration Research},
year = {2024},
volume = {19},
number = {9},
pages = {1961--1966},
doi = {10.4103/1673-5374.390973}
}
EUVIMED